Table 1.
Characteristics of the trial patients at baseline.
| Demographics | Study group (n = 40) | Control group (n = 45) | P value |
|---|---|---|---|
| Age (years) | 64.53 ± 14.89 | 69.03 ± 12.62 | 0.189 |
| Weight (kg) | 53.90 ± 6.60 | 53.08 ± 8.75 | 0.675 |
| Sex (male : female) | 28 : 12 | 28 : 17 | 0.450 |
| APCAHE II | 29.67 ± 7.68 | 30.39 ± 7.10 | 0.693 |
| SOFA (sepsis-related organization failure assessment) | 12.93 ± 2.46 | 11.71 ± 2.85 | 0.190 |
| Comorbidities | |||
| Severe pneumonia | 15 | 13 | 0.399 |
| Peritonitis | 6 | 11 | 0.277 |
| Acute exacerbation of chronic obstructive pulmonary disease | 10 | 13 | 0.549 |
| Severe acute pancreatitis | 4 | 1 | 0.165 |
| Biliary tract infection | 1 | 3 | 0.327 |
| Urinary system infection | 2 | 2 | 1.000 |
| Fracture with infection | 1 | 0 | 0.488 |
| Multiple organ dysfunction syndrome | 1 | 1 | 0.741 |
| Burn | 0 | 1 | 0.512 |